Get complete Patent Opposition Report for Moderna Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Moderna Therapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3115064Rna-Coded AntibodyCUREVACAug 24, 2022

Explore Moderna Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions10
EP2922554Feb 23, 2022Terminally Modified Rna1
EP3019619Aug 25, 2021Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use2
EP3492109Mar 4, 2020Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof2